Genetically engineered mesenchymal stromal cells producing anti-CTLA-4 antibodies as targeted checkpoint inhibitor therapy in pancreatic cancer in KPC mouse model

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date1/06/2017 → 1/06/2021